Health
New ‘SINT1A‘ study explores potential of a probiotic to prevent type 1 diabetes in children – News-Medical.Net
Type 1 diabetes is the most common metabolic disease in children and adolescents worldwide. It can be particularly dangerous as often there is no diagnosis until…
Type 1 diabetes is the most common metabolic disease in children and adolescents worldwide. It can be particularly dangerous as often there is no diagnosis until severe and sometimes life-threatening symptoms have already developed. The new ‘SINT1A‘ study explores the potential of a specific probiotic to strengthen the immune system early-on in children with increased genetic risk of type 1 diabetes, and thus prevent its development.
SINT1A is led by Helmholtz Zentrum Muenchen, and part of the…
-
Noosa News12 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Business15 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth
-
Noosa News15 hours agoAustralia’s biggest sheep drive, and the young drover history forgot
-
General10 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury